Balachandran

#Data Analyst || #Business Intelligence Analyst || # Stock Market || #Investing

[The Spiritual Trader @ArindamPramnk]

📊 GRSE | MONTHLY CHART ANALYSIS

💰 LTP: ₹1,988

🏗 STRUCTURE

📈 Long-term uptrend since 2022
🚀 Big rally 2024 to mid-2025 (top ~₹3,400)
↔️ Now ranging between ₹2,000 and ₹3,000
🔻 Lower highs, 3 red monthly candles
⚠️ Testing the long-term rising trendline

☑️ CONFIRMATION

❌ Below the 10-month avg (₹2,309)
🟡 Sitting on the 20-month avg (₹1,756)
📉 RSI 47, neutral and falling
🟢 Bullish: monthly close above ₹2,300
🔴 Bearish: monthly close below ₹1,750

🚧 RESISTANCE

R1: ₹2,300 – 2,350
R2: ₹2,800 – 2,900
R3: ₹3,300 – 3,450 (major top)

🛡 SUPPORT

S1: ₹1,950 – 1,990 (trendline)
S2: ₹1,750 – 1,760 (20-month avg)
S3: ₹1,200 – 1,300 (2025 base)

📶 VOLUME

🔥 Peak volume came in the 2025 breakout
😴 The recent fall is on low volume, so it looks like a correction
⏳ No buying volume yet
👀 Wait for a volume spike on a green monthly candle

🎯 OVERALL VIEW

Uptrend in correction, testing trendline support. This is a watch and wait zone actually a best support zone to end correction

⚠️ For educational purposes only. Not investment advice. Do your own research.

[Balachandran @aktbala]

@WealthEnrich TD Power

[Darvas Box Trader @darvasboxtrader]

We have added one more feature in https://t.co/0j1oo0i6qr

Mantis Eye..👁️

Just mention the stocks name, it will check the technical health of that stock.

Check it out and share your feedbacks ...✍️

#DARVAS🥸

[KnowledgeX @SudhirN94847744]

🔔 Stock Watch – Zensar Technologies Ltd

Currently trading ~ ₹480
Market Cap ~ ₹10,900 Cr

Interesting times ahead!
🧵⤵️

[Mens Canvas @MensCanvas]

7 Sexy Looks for Stylish Men:

1.

[Trade Brains Portal @TbPortal]

🏢 Karnataka’s Data Centre Push: 5 Stocks to Watch

[Gnyanad Bhatt @Asset_Architect]

🔥 MY “ ANYDAY BUY THE DIP” WATCHLIST 🔥

These are the names where every meaningful dip is a blessing for me. I’d rather use weakness as an opportunity than panic over volatility. 👀

IOL Chemicals
KMC Speciality
Patil Automation
Morepen Laboratories
Bodal Chemical
Action Construction
VA Tech Wabag
Engineers India
Unimech Aerospace
Venus Pipes
Menon Bearings
SSWL
Raymond
Balaji Amines
Shilpa Medicare
Kwality Pharmaceuticals
Neogen Chemicals
Ind Swift Laboratories
Sona Comstar
Electronics Mart
GNG electronics
Groww
Angel One
Aegis Logistics
Shadowfax
Titan
TD Power Systems
JG Chemicals
Marksans Pharma

Market gives you two choices: panic on every dip or use the weakness to build conviction.

For these names, I know which side I’m on. 🚀📈

#Dip #StockMarket #Trading #Investing #Multibagger

[Trader Vishal Sharma @tradervishal87]

Top 3 Stocks Price under 20 Rs i am Tracking for 5 to 10X 🎯

My Top pick : 1 & 3 💹

Repost & Bookmark this 🔖

1. #SYNCOMF

MARKET CAP - 2200 Cr
PE -26
Debt - 0
Every Year Profit increased March 26 Profit 75 Cr
Promoters holding 50%+

Best Buy in Dips 10-15 for long Term🎯

[Amit Multibagger Stocks @1big_bull]

Electrical Connectivity - Sterlite Technologies and HFCL

Precision Engineering- MTAR Tech, Sansera engineering, Azad Engineering, Omnitech, Aequs

Pharma / CDMO - Morepen lab, Sakar Healthcare , Aarti Pahrma, Shilpa Medicare, Sai Life, Laurus Lab, Kwality Pharma, Gland Pharma, Sudeep Pharma, Acutaas, Divis lab, Beta Drugs, Neuland

Consumer and Consumer Tech – Cupid, Timex, Ethos, Milky Mist, Shadowfax technology, HOAC Foods

Jewellery- Deepa Jewel, Lalithaa Jewel, AJC Jewel, Sky Gold, Titan, Kalyan, PN Gadgil, PNGS Reva

Cooling – KRN Heat Exchanger, Aeroflex

Capital Goods - Welspun Corp, Man Industries

Auto and Auto ancillary - Sedemac Mechatronics, Ather Energy, Lumax Auto Tech, SJS, Divgi torq, Craftsman Automation, Uno Minda, Sona BLW, Bosch, Gabriel India, TVS Motor Bajaj Auto, Rolex rings, OBSC Perfection, Pricol, Steel Strips

GPUs, Supercomputers- E2E networks, Netweb, ESDS

Power Infrastructure - TD Power Systems, GE Vernova T&D, Yash High voltage, Pitti Engineering, Kirloskar Oil Engines, ABB India, Siemens India, Siemens Energy, Schneider Electric, Hitachi Energy India, Cummins India, CG Power, Quality Power

Cables– Prime Cable, VMarc, Dynamic cable, RR Kabel, KSH International, Finolex, Universal Cable, Polycab

[Ankush Prajapati @Mf360WW]

Goldman Sachs India AI Enablers:
Full 42-Company List

[The Spiritual Trader @ArindamPramnk]

Azad Engineering — A Setup Worth Tracking 📈

The stock has repeatedly followed a simple structure:

Strong upmove → Descending Channel → Breakout → Next leg higher

Now, another descending channel looks ready for a breakout around ₹2,850–2,900, with a strong expansion in volume

Key levels 👇

• Above ₹2,900-2950 on closing basis → breakout confirmation
• Risk zone: ₹2,700–2,720

What I like most here? Price Action + Volume are aligning

Sometimes you don't need 10 indicators. A clean structure, breakout and volume can tell the story

Educational purpose only. Not a buy/sell recommendation.

[Ginger Investor @GingerInvest44]

My favourite stocks which gave excellent results and worth tracking in future 🔥🔥

✅Bookmark - Part 1 of 4

Forgings or Castings
- MM Forgings
- Happy forgings
- Sona camster
- RK Forge

Precision Engineering
- Sansera
- Azad engineering
- Omnitech engineering
- NRB bearings
- Shivalik bimetal controls
- Uniparts India

Tubes/Pipes
- Welspun corp
- Dee developement engineers
- Man industries
- Venus pipes
- Sambhav Steel tubes

Metals
- Lloyds metals
- Hindustan Zinc
- Jayeswal neco industries

Part 2 🔜

[Kaustubh Yeole @KaustubhYeole]

🔥𝗧𝗼𝗽 𝟮𝟬 𝗦𝗺𝗮𝗹𝗹-𝗖𝗮𝗽 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗪𝗶𝘁𝗵 𝗗𝘂𝗿𝗮𝗯𝗹𝗲 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗠𝗼𝗮𝘁𝘀 𝗧𝗼 𝗦𝘁𝘂𝗱𝘆 & 𝗧𝗿𝗮𝗰𝗸 👀📈

• Azad Engineering

• Quality Power

• Aequs

• Apollo Micro Systems

• TD Power Systems

• MTAR Technologies

• Shaily Engineering Plastics

• Transformers & Rectifiers India

• Precision Wires India

• Sigma Advanced Systems

• DEE Development Engineers

• Atlanta Electricals

• Krishna Defence

• KSH International

• Kernex Microsystems

• Sedenac Mechatronics

• Fujiyama Power

• Indo-MIM

• Omnitech Engineering

• Vidya Wires

👀 Which company is on your watchlist ?

#StockMarket #IndianStocks #SmallCapStocks #StocksToWatch

[Mithun Sarkar @MithunSarkari]

Pharma : The space still has the fuel.

Adding a few more names , do study.

No Recommendations.

1. Wockhard
2. Morepean lab
3. Anlon health
4. Indswift labs
5. Shilpa med(my top conviction)
6. Strides pharma
7. Aarti pharmalabs
8. Fredun pharma
9. Sudeep pharma
10. Innova Captab

[Value_Investor @Value_Tracking]

📊 STOCKS IN NEWS | KEY MARKET UPDATES 🚨

A quick look at major corporate developments, growth triggers and risk factors across Indian stocks.

📊 Key Highlights:

🟢 GROWTH & EXPANSION
• Arvind SmartSpaces — Bengaluru bookings cross ₹500 Cr
• Coforge — Expands AgenticOps capabilities
• Cupid — Raises FY27 revenue & profit guidance
• HCLTech — AI-led transformation mandate with M Group
• Avenue Supermarts — Store count reaches 513
• Dhanuka Agritech — Launches POLIN fungicide
• Spectrum Electrical — Maharashtra ITI infrastructure MoU
• Lemon Tree Hotels — Opens 48-room Nashik hotel

🟠 CORPORATE ACTIONS
• Aditya Infotech — QIP opens at ₹3,648.43 floor price
• NATCO Pharma — Rights issue proposal up to ₹1,300 Cr
• JSW Dulux — 1:10 stock split; Oct 22 record date
• Persistent Systems — Nagarro stake reaches 83.25%
• NHPC — Amalgamation hearing on Sep 28
• 360 ONE WAM — New CEO appointment announced
• IRB Infrastructure — Non-core asset monetisation approved
• TeamLease — Exits Crystal HR & Security Solutions

🔴 RISK & CAUTION
• Veranda Learning — ₹111 Cr promoter pledge
• Sapphire Foods — ₹538.31 Cr GST notices
• Punjab & Sind Bank — Strike notice for Sep 28–30
• Vishnu Chemicals — FZE winding-up delayed

💡 Key Insight: Corporate actions can materially affect earnings visibility, capital structure and near-term sentiment—each development needs company-specific analysis.

🎯 Verdict: Track the news, then verify the numbers, valuation and business impact before taking an investment decision.

#StocksInNews #IndianStocks #StockMarketIndia #StockMarketNews #StocksToWatch #CorporateActions #GrowthStocks #BusinessUpdates #IndianStockMarket #InvestingIndia #FundamentalAnalysis #MarketInsights #NSEStocks #BSEStocks #ValueTrackInvesting

[CA Paaras Gangwal @ThetaVegaCap]

If u dont have

Pharma
Auto Ancillaries
Defence
Precision Engineering
CDMO

Then Your portfolio may be lagging with huge margin

Be with Themes
Buy Winners

#ThematicInvesting
#MomentumInvesting

[Advait Arora @WealthEnrich]

Some unique stocks in the small cap pharma space are again becoming interesting. I can spot a combination the market loves to reward big in this sector: strong sales growth, rising profits, improving ROCEs & regulated market expansion.

These companies are between ₹1,000 Cr & ₹6,500 Cr MCap & going forward earnings growth can still materially change the size of the business in next few years.

1. Aarti Pharmalabs Limited

Aarti Pharmalabs already operates at nearly ₹6,500 Cr market cap, yet sales CAGR still stands above 20% while profit CAGR remains above 30%. ROCE above 17% and EV/EBITDA below 17 are strong numbers for a company at this scale. The business benefits from both API and CDMO exposure, which gives multiple revenue streams instead of dependence on one product cycle.

2. Innova Captab Limited

Innova Captab reported quarterly sales above ₹447 Cr with nearly 42% YoY growth. Quarterly profit rose around 29%, while 3 year sales CAGR and profit CAGR both remain above 20%. At roughly ₹5,000 Cr market cap, this is becoming one of the larger emerging CDMO and branded formulation stories in the small and midcap pharma space.

3. Senores Pharmaceuticals Limited

Senores has moved from a ₹215 Cr revenue company in FY24 to more than ₹620 Cr revenue in FY26. Profit during the same period increased from ₹33 Cr to around ₹122 Cr. Three year sales CAGR now stands above 160% while profit CAGR is near 140%. The market is clearly pricing future US commercialization and ANDA expansion, which is why the company already commands nearly ₹5,000 Cr market cap despite a high PE.

4. Bliss GVS Pharma Limited

Bliss GVS reported quarterly profit growth above 120% while EV/EBITDA still remains near 12. Profit CAGR over 3 years is already above 50%, which is substantial for a company with market cap around ₹3,000 Cr. The company operates in niche dosage segments where competition intensity is lower compared to mainstream oral generic businesses.

5. Syncom Formulations (India) Limited

Syncom Formulations stands out mainly because the valuation still looks modest relative to growth. Sales CAGR is nearly 29%, profit CAGR is around 35%, ROCE remains above 18%, while PE is still below 20. For a company with market cap near ₹1,300 Cr, these operating numbers are strong.

6. Fredun Pharmaceuticals Limited

Fredun Pharmaceuticals reported quarterly sales growth above 57% while quarterly profit almost doubled YoY. Three year profit CAGR is approaching 50% and ROCE remains close to 19%. The company is still only around ₹1,300 Cr market cap, so sustained execution can materially change investor attention over the next few years.

7. Accent Microcell Limited

Accent Microcell has one of the strongest statistical profiles in this group. ROCE is already close to 25%, profit CAGR is above 53%, and EV/EBITDA remains below 16. Market cap is still only around ₹1,000 Cr despite quarterly sales growth above 50% and profit growth above 55%.

8. Remus Pharmaceuticals Limited

Remus Pharmaceuticals has already crossed ₹400 Cr quarterly revenue with nearly 47% YoY growth. ROCE is close to 20% while EV/EBITDA remains below 19. For a company with market cap slightly above ₹1,000 Cr, the recent revenue scale-up has been substantial.

▪️What makes these companies worth tracking is not just growth but as its clear that profits and ROCE are improving together & valuations are still below what the market usually assigns to established pharma growth stories.
▪️Going forward if execution continues over the next 3 to 4 years, some of these businesses can become materially larger than where they stand today !
Keep an eye on these potential outperformers !

[Aditya Kondawar @aditya_kondawar]

The ₹4 lakh crore Data Center opportunity may be much bigger than just Data Center companies! 🇮🇳

Jefferies expects India’s data center capacity to grow ~5x, driving ~$45bn of facility capex over the next 5 years

Key beneficiaries: Data center operators, EPC & construction, real estate, power equipment, cooling solutions, and network infrastructure.

In every large capex cycle, some of the biggest opportunities emerge among the picks-and-shovels suppliers. India’s data center boom could create an entire ecosystem of beneficiaries — power and cooling may be as important as the servers themselves!

No reco strictly

[The Spiritual Trader @ArindamPramnk]

📊 TECHNICAL ANALYSIS | CHART STUDY | TRANSRAIL LIGHTING A very simple but interesting weekly setup developing here:

👉Double Bottom Setup — Price has again reacted strongly from the major ₹394–400 support zone

👉Strong Reversal Candle — This week's sharp recovery from support shows buyers stepping in again ₹450

Reclaimed — Holding above this zone keeps the recovery structure positive

₹533–535 = Minimum Target Zone — This is the first major resistance we are tracking from current levels

👉Trendline Breakout = Bigger Move Possible above 534 — A clean breakout above the falling trendline can open the door for a much larger reversal.

👉Support ₹394–400 → CMP ~₹477 → Minimum Target ₹533–535

🎯 Keep it simple: Double Bottom + Major Support + Falling Trendline. Let's track how the structure develops

📈 Educational chart study only; not a buy/sell recommendation.

[Er. Vipin | Multibagger Bloodhound @Er_Vpin]

Most people only chase stocks that already ran 10X

The real money is in names that looked dead… then quietly started working again. 15 midcaps just showed up on the same

Apar Industries
Syrma SGS
Shilpa Medicare
Avalon Tech
Sigma Advanced Systems
Welspun Enterprises
Yatharth Hospital
Precision Wires
GNG Electronics
Tanfac
Timex Group
Venus Pipes
Filatex
Yash Highvoltage
Talbros Auto

Same pattern: profits turning, order books filling, market still treating some of them like they’re broken.

The crowd always arrives late to a turnaround.

Which one are you tracking before it becomes obvious?

#StockMarket #Nifty #Investing